16 Jan 2015 --- A new study led by researchers at Dana-Farber Cancer Institute found that clinical trial patients with metastatic colorectal cancer who had high levels of vitamin D in their bloodstream prior to treatment with chemotherapy and targeted drugs, survived longer, on average, than patients with lower levels of the vitamin.
